Mr. Jim O'Shea

• 
  www.sec.gov/Archives/edgar/data/319379/0000950130-01-50 - [Cached Version]
  Published on: 4/20/2001    Last Visited: 9/16/2001  

  Withheld ------- --- -------- James C. O'Shea
  
  9 , 383 , 942

• 
  www.sec.gov/Archives/edgar/data/1200144/0001200144-06-0 - [Cached Version]
  Published on: 6/1/2006    Last Visited: 6/16/2006  

  0001200144 OSHEA JAMES C 20245 SW 95TH AVENUE TUALATIN OR 97062 1 1 0 1 President/CEO Chairman

• 
  portland.bizjournals.com/gen/executive.html?excode=0B0F - [Cached Version]
  Published on: 6/25/2008    Last Visited: 6/25/2008  

  James C. O'Shea Executive Profile
  ...
  James C. O'Shea Executive Profile
  
  Executive Profiles > James C. O'Shea Profile
  ...
  James C. O'Shea
  
  Chairman, President & CEO Bioject Medical Technologies Inc.

• 
  www.sec.gov/Archives/edgar/data/1200144/0001200144-06-0 - [Cached Version]
  Published on: 8/24/2006    Last Visited: 8/26/2006  

  0001200144 OSHEA JAMES C 20245 SW 95TH AVE TUALATIN OR 97062 1 1 0 0 Chairman/CEO and President

• 
  portland.bizjournals.com/portland/gen/executive.html?ex - [Cached Version]
  Published on: 5/19/2008    Last Visited: 5/19/2008  

  James C. O'SheaPortland Business Journal: James C. O'Shea Executive Profile
  ...
  James C. O'Shea
  
  Chairman, President & CEO Bioject Medical Technologies Inc.

• 
  www.sec.gov/Archives/edgar/data/810084/0001047469-03-01 - [Cached Version]
  Published on: 4/29/2003    Last Visited: 10/29/2003  

  James C. O'Shea
  ...
  JAMES C. O'SHEA has served as our Chairman, President and Chief Executive Officer since March 1995.From January 1989 to March 1995, Mr. O'Shea was President and Chief Operating Officer of Biopure Corporation, a developer of red blood cell substitutes.Prior to 1989, Mr. O'Shea was Executive Vice President of Marketing and Scientific Affairs at Delmed Inc., a manufacturer of peritoneal dialysis solutions and parenteral products.He is a member of the Board of Directors of PSC, Inc., serving as Chairman of the Compensation Committee.

• 
  www.sec.gov/Archives/edgar/data/810084/0000891020-02-00 - [Cached Version]
  Published on: 9/5/2002    Last Visited: 9/7/2002  

  James C. O'Shea
  ...
  JAMES C. O'SHEA has served as Chairman, President and Chief Executive Officer of BIOJECT MEDICAL TECHNOLOGIES INC since March 1995.Prior to joining Bioject, he was President and Chief Operating Officer of Biopure Corporation, a developer of red blood cell substitutes.Prior to 1989, Mr. O'Shea was Executive Vice President of Marketing and Scientific Affairs at Delmed Inc., a manufacturer of peritoneal dialysis solutions and parenteral products.He is a member of the Board of Directors of PSC, Inc., serving as Chairman of the Compensation Committee and previously serving as Chairman of the Executive Committee.

• 
  www.sec.gov/Archives/edgar/data/810084/0000891020-02-00 - [Cached Version]
  Published on: 7/19/2002    Last Visited: 7/23/2002  

  James C. O'Shea Chairman, Chief Executive Officer and President
  
  ...
  JAMES C. O'SHEA has served as Chairman, President and Chief Executive Officer of BIOJECT MEDICAL TECHNOLOGIES INC since March 1995.Prior to joining Bioject, he was President and Chief Operating Officer of Biopure Corporation, a developer of red blood cell substitutes.Prior to 1989, Mr. O'Shea was Executive Vice President of Marketing and Scientific Affairs at Delmed Inc., a manufacturer of peritoneal dialysis solutions and parenteral products.He is a member of the Board of Directors of PSC, Inc., serving as Chairman of the Compensation Committee and previously serving as Chairman of the Executive Committee.

• 
  www.sec.gov/Archives/edgar/data/319379/0000912057-02-01 - [Cached Version]
  Published on: 4/15/2002    Last Visited: 6/28/2002  

  James C. O'Shea
  ...
  James C. O'Shea has served as a director of PSC INC since 1989.He has been Chairman of the Board and Chief Executive Officer of Bioject Medical Technologies, Inc., a medical device manufacturer of needle-free injection systems in Portland, Oregon, since April 1995.Prior thereto, he was President of Biopure Corporation, a biotechnology company in Cambridge, Massachusetts, from January 1989 until April 1995.

• 
  www.sec.gov/Archives/edgar/data/810084/0000950109-01-50 - [Cached Version]
  Published on: 7/27/2001    Last Visited: 6/26/2002  

  The Class Three nominees are Mr. James C. O'Shea, Dr. John Ruedy and Dr. Sandra Panem.
  ...
  James C. O'Shea
  ...
  JAMES C. O'SHEA has served as Chairman and Chief Executive Officer of BIOJECT MEDICAL TECHNOLOGIES INC since March 1995.Prior to joining Bioject, he was President and Chief Operating Officer of Biopure Corporation, a developer of red blood cell substitutes.Prior to 1989, Mr. O'Shea was Executive Vice President of Marketing and Scientific Affairs at Delmed Inc., a manufacturer of peritoneal dialysis solutions and parenteral products.He is a member of the Board of Directors of PSC, Inc., serving as Chairman of the Compensation Committee and previously serving as Chairman of the Executive Committee.

Page:  1 2 3 4 5